We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.58B
AUM Growth
+$66.2M
Cap. Flow
-$35.1M
Cap. Flow %
-2.23%
Top 10 Hldgs %
38.87%
Holding
195
New
31
Increased
63
Reduced
42
Closed
47

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$53.9M
2
STWD icon
Starwood Property Trust
STWD
+$42.6M
3
VSAT icon
Viasat
VSAT
+$34.9M
4
YELP icon
Yelp
YELP
+$31M
5
TMUS icon
T-Mobile US
TMUS
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Healthcare 19.96%
3 Financials 15.02%
4 Real Estate 13.01%
5 Communication Services 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
101
NetEase
NTES
$76.5B
$1.05M 0.07%
18,500
-3,500
-16% -$188K
AET
102
DELISTED
Aetna Inc
AET
$1.05M 0.07%
+8,200
New +$1.03M
PCRX icon
103
Pacira BioSciences
PCRX
$960M
$1.04M 0.07%
+22,800
New +$985K
CLVS
104
DELISTED
Clovis Oncology, Inc.
CLVS
$1.01M 0.06%
15,900
+100
+0.6% +$6.08K
PHF
105
DELISTED
Pacholder High Yield
PHF
$958K 0.06%
124,140
+46,340
+60% +$356K
FDEU
106
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
$908K 0.06%
52,600
-48,700
-48% -$802K
VSA
107
VisionSys AI
VSA
$7.85M
$899K 0.06%
21
+14
+200% +$563K
IGD
108
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$504M
$851K 0.05%
+115,900
New +$825K
HQL
109
abrdn Life Sciences Investors
HQL
$590M
$825K 0.05%
48,545
DHF
110
BNY Mellon High Yield Strategies Fund
DHF
$165M
$811K 0.05%
239,107
+27,807
+13% +$94.3K
INCY icon
111
Incyte
INCY
$24.7B
$789K 0.05%
+5,900
New +$751K
DBL
112
DoubleLine Opportunistic Credit Fund
DBL
$275M
$702K 0.04%
29,420
-13,980
-32% -$328K
PHT
113
DELISTED
Pioneer High Income Fund
PHT
$684K 0.04%
69,300
CAF
114
Morgan Stanley China A Share Fund
CAF
$242M
$675K 0.04%
35,100
KERX
115
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$657K 0.04%
106,700
+28,100
+36% +$154K
BLUE
116
DELISTED
bluebird bio
BLUE
$645K 0.04%
548
-147
-21% -$150K
UTHR icon
117
United Therapeutics
UTHR
$21.5B
$645K 0.04%
4,500
FFC
118
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$739M
$639K 0.04%
31,100
-5,900
-16% -$117K
BCX icon
119
BlackRock Resources & Commodities Strategy Trust
BCX
$968M
$606K 0.04%
+70,500
New +$607K
NTLA icon
120
Intellia Therapeutics
NTLA
$1.59B
$600K 0.04%
+42,600
New +$572K
FAM
121
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$579K 0.04%
+49,806
New +$566K
JFR icon
122
Nuveen Floating Rate Income Fund
JFR
$1.2B
$538K 0.03%
+46,700
New +$553K
CBM
123
DELISTED
Cambrex Corporation
CBM
$501K 0.03%
+9,100
New +$486K
ACP
124
abrdn Income Credit Strategies Fund
ACP
$577M
$458K 0.03%
+33,929
New +$458K
PGZ
125
Principal Real Estate Income Fund
PGZ
$63.7M
$435K 0.03%
24,812
+212
+0.9% +$3.54K

Similar funds

Clough Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Clough Capital Partners held 195 positions worth $1.58B, up 4.4% from $1.51B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Clough Capital Partners's Q1 2017 filing shows 31 new, 63 increased, 42 reduced and 47 closed positions. Its largest new stake was Cognizant: 219,300 shares worth $13.1M. The largest sale was EOG Resources, an estimated $31M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Clough Capital Partners's largest Q1 2017 buy was Cognizant: 219,300 shares worth $13.1M.
  • Clough Capital Partners added most to Apple in Q1 2017, an estimated $53.9M increase.
  • Clough Capital Partners's biggest Q1 2017 reduction was Lennar Class A, cutting an estimated $18.8M.
  • Clough Capital Partners fully exited EOG Resources in Q1 2017, selling an estimated $31M.
  • Clough Capital Partners's ten largest holdings make up 39% of its $1.58B portfolio in Q1 2017.
  • Clough Capital Partners opened 31 new positions and closed 47 in Q1 2017.
  • Clough Capital Partners's portfolio value rose 4.4% quarter-over-quarter to $1.58B.

Based on Clough Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.